ArticleBMC genomic data2026
Whole-genome sequences of Enterobacter cloacae H5 and Enterobacter bugandensis H6 isolated from patients in Khartoum State, Sudan.
Article in BMC genomic data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEnterobacter species are important nosocomial pathogens, mainly due to multidrug resistance (MDR). This study reports the whole-genome sequences of Enterobacter cloacae H5 and Enterobacter bugandensis H6. DATA DESCRIPTION: Digital DNA-DNA hybridization (dDDH) confirmed species identity: H5 (91.8% with E. cloacae ATCC 13047) and H6 (89.3% with E. bugandensis EB-247). H5 has 46 contigs, 4,867,245 bp, GC 54.97%; H6 has 27 contigs, 4,616,569 bp, GC 56.05%. Phylogenetic analysis grouped H5 within E. cloacae and H6 within E. bugandensis. Both genomes harbor multiple antimicrobial resistance (AMR) genes. H5 includes β-lactamase CMH-16, FosA2, efflux pumps (oqxA, emrB), and regulators (ramA, baeR, baeS). H6 includes β-lactamase ACT-146, FosA2, efflux pumps (oqxA, emrB, msbA), regulators (baeR, baeS), and target modification gene ArnT. These genomes highlight the clinical significance of these strains and provide essential resources for understanding the genomic basis of antimicrobial resistance in Sudanese Enterobacter isolates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.